Business Trip Podcast

Active
Has guests
Greg Kubin & Matias Serebrinsky
[email protected]
Categories
Mental Health Health & Fitness Alternative Health Science Society & Culture
Audience & Performance Metrics
840 - 1.4K listeners Female/Male 4.9 rating 56 reviews 59 episodes USA
Monetization Metrics
30s Ad: $25 - $28 60s Ad: $29 - $32 CPM Category: Science
Socials metrics & links
No data followers Twitter
Podcast Links
Website RSS Apple Podcast Spotify

Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more. 

Producers, Hosts, and Production Team

No producer information available yet. Click "Find producers" to search for the production team.

Emails, Phones, and Addresses

Contact Page Emails

Emails
Phone Numbers

No phone numbers found.

Addresses

No addresses found.

Form

No form detected on this page.

General Website Emails

No website emails found.

Externally Sourced Emails

  • gr***@businesstrip.fm

RSS Emails

No RSS emails found.

Recent Hosts, Guests & Topics

Here's a quick summary of the last 5 episodes on Business Trip.

Hosts

Matias Serebrinsky Greg Kubin

Previous Guests

Ying-Hui Fu
Ying-Hui Fu, PhD, is a Professor of Neurology at UCSF and a world leader in the genetics of sleep. Her lab has discovered the first-known genes behind natural short sleepers. Her work bridges human genetics and neuroscience to uncover how to modulate sleep for brain health, aging, and neurodegenerative diseases.
Justin Mares
Justin Mares is the co-founder of TrueMed and Kettle & Fire, companies focused on improving health through innovative food products and healthcare solutions. He has a background in entrepreneurship and investment, with a keen interest in how startups can disrupt traditional healthcare systems. Justin is known for his contrarian views on health and wellness, advocating for changes in the food system and addressing the incentives within the pharmaceutical industry.
Brooks Leitner
Brooks Leitner is a partner at PsyMed Ventures, bringing a wealth of experience from his background as an MD/PhD. He has a strong academic foundation with training from Yale University and the National Institutes of Health (NIH). His expertise lies in the intersection of neuroscience and venture capital, focusing on innovative approaches to brain and mental health therapies. Brooks advocates for a human-first approach in research and investment, emphasizing the importance of clinical insights over traditional animal models.
Nir Grossman

No additional bio available.

James Adams

No additional bio available.

Topics Discussed

genetics sleep science neuroscience human performance brain health aging neurodegenerative diseases medical ethics Alzheimer's disease autism US healthcare startups chronic illness food system environmental toxins pharma incentives body health mental health PsyMed Ventures neuroscience innovation venture investing therapeutics medical devices diagnostics consumer health AI-enabled care platforms temporal interference brain stimulation neurotechnology non-invasive stimulation deep brain stimulation Alzheimer's epilepsy depression traumatic brain injury microbiome therapy gut-brain axis therapeutic approaches nutritional interventions environmental factors toxins

YouTube Channel

Podcast has no YouTube channel.

Instagram Profile

Podcast has no Instagram profile.

Episodes

Here's the recent few episodes on Business Trip.

0:00 33:11

The 4-Hour Sleepers Redefining Human Limits with Ying-Hui Fu of UCSF

Guests
Ying-Hui Fu
Keywords
genetics sleep science neuroscience human performance brain health aging neurodegenerative diseases medical ethics Alzheimer's disease autism

Matias and Greg interview Ying-Hui Fu, PhD, is a Professor of Neurology at UCSF and a world leader in the genetics of sleep. Her lab has discovered the first-known genes behind natural short sleepers. Her work bridges human genetics and neuroscience to uncover how to modulate sleep for brain health, aging, and neurodegenerative diseases.

In this episode, we discuss:

  • How some people thrive on 46 hours of sleep with rare genetic mutations
  • Why sleep efficiency is more important than total hours slept
  • What short sleeper genes reveal about preventing Alzheimers and autism
  • Why current sleep research tools miss deeper brain activity patterns
  • Whats next in sleep science with potential therapies

Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky & Greg Kubin
Produced by Caitlin Ner & Nico V. Rey

Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank

0:00 37:39

What's wrong with US healthcare and how startups can fix it, with Justin Mares

Guests
Justin Mares
Keywords
US healthcare startups chronic illness food system environmental toxins pharma incentives brain health body health

Matias and Greg interview Justin Mares, co-founder of TrueMed and Kettle & Fire on current US healthcare and how startups have the opportunity to change the system.

In this episode, we discuss:

  • How the US system profits from chronic illness
  • Fixing the food system, environmental toxins, pharma incentives & more
  • Opportunities for founders building in brain and body health.
  • Contrarian ideas Justin is investing in today

Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky & Greg Kubin
Produced by Caitlin Ner & Nico V. Rey 

Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank

0:00 49:38

Frontier investable areas in brain health with PsyMed Ventures

Guests
Brooks Leitner
Keywords
brain health mental health PsyMed Ventures neuroscience innovation venture investing therapeutics medical devices diagnostics consumer health AI-enabled care platforms

Matias and Greg sit down with Brooks Leitner, the newest venture partner at PsyMed Ventures, to explore the future of brain and mental health investing. Brooks, an MD/PhD with deep experience from Yale and the NIH, shares his insights on how a human-first approach is reshaping neuroscience innovation and venture investing. 

In this episode, we discuss:

  • Broadening the Thesis: Evolving from a psychedelics-only focus to a comprehensive neuro investment strategy.
  • Human-First Research: Shifting from animal models to clinical insights for better brain therapies.
  • Key Investment Areas: Therapeutics, medical devices, diagnostics, consumer health, and AI-enabled care platforms.
  • Early-Stage Conviction: Leveraging a prepared mind to spot breakthrough opportunities.
  • Personal & Future Insights: Leadership challenges and the vision for the future of neuro investing.

Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky & Greg Kubin
Produced by Jonathan A. Davis,  Nico V. Rey & Caitlin Ner

Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank

0:00 22:07

Temporal Interference: The Future of Brain Stimulation with Nir Grossman

Guests
Nir Grossman
Keywords
temporal interference brain stimulation neurotechnology non-invasive stimulation deep brain stimulation neuroscience innovation Alzheimer's epilepsy depression traumatic brain injury

Matias and Greg interview Dr. Nir Grossman, one of the world’s leading researchers in neurotechnology. Nir is a lecturer in the Department of Brain Sciences at Imperial College London and a founding fellow of the UK Dementia Research Institute. 

In this episode, we discuss:

  • What is temporal interference (TI), a non-invasive stimulation method
  • A comparison of TI with deep brain stimulation (DBS)
  • How physics plays a crucial role in neuroscience innovation
  • Translating TI academic research to clinical use
  • TI’s role in treating Alzheimer’s, epilepsy, depression, and traumatic brain injury

Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky & Greg Kubin
Produced by Jonathan A. Davis,  Nico V. Rey & Caitlin Ner

Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank

0:00 40:03

The State of Autism Part 2 with James Adams of Gut-Brain-Axis Therapeutics Inc.

Guests
James Adams
Keywords
autism microbiome therapy gut-brain axis therapeutic approaches nutritional interventions environmental factors toxins

Greg and Matias interview Dr. James Adams, professor and autism researcher at Arizona State University and President of Gut-Brain-Axis Therapeutics, on groundbreaking research in autism.

In this episode, we discuss:

  • The latest advancements in microbiome therapy for autism
  • How the gut-brain axis is shaping new therapeutic approaches
  • The role of nutritional interventions in supporting individuals with autism
  • Environmental factors and toxins influencing autism development

Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky & Greg Kubin
Produced by Jonathan A. Davis,  Nico V. Rey & Caitlin Ner

Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank



Ratings

Global:
4.9 rating 56 reviews

USA

4.9 ratings 50 reviews

UK

5.0 ratings 4 reviews

Canada

5.0 ratings 2 reviews

Ireland

0.0 ratings 0 reviews

Australia

0.0 ratings 0 reviews

New Zealand

0.0 ratings 0 reviews

Singapore

0.0 ratings 0 reviews

South Africa

0.0 ratings 0 reviews